Clinical effectiveness and cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men: Risk calculators for real-world decision-making

Medicine & Life Sciences

• Pre-Exposure Prophylaxis 97%
• Sexual and Gender Minorities 70%
• Cost-Benefit Analysis 59%
• Decision Making 56%
• Numbers Needed To Treat 47%
• HIV 47%
• Costs and Cost Analysis 42%
• Quality-Adjusted Life Years 42%
• Population 8%
• Condoms 8%
• Clinical Decision-Making 8%
• Patient Education 7%
• Uncertainty 7%
• HIV Infections 6%
• Public Health 5%
• Therapeutics 2%

Agriculture & Biology

• quality-adjusted life year 100%
• cost effectiveness 74%
• decision making 68%
• disease control 60%
• gender 42%
• patient education 21%
• risk profile 18%
• therapeutics 17%
• HIV infections 17%
• uncertainty 11%
• risk factors 11%
• public health 10%
• mouth 8%
• methodology 3%

Chemical Compounds

• Antiretroviral 98%